Health

Results: 6985-6996 of 9380

PR Newswire associated0

Onconic Therapeutics Announces Positive Phase 3 Results for JAQBO at Digestive Diseases Week 2024

JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)

Stryker's Gamma4 Hip Fracture Nailing System is designed to treat hip and femur fractures. Its nail design is informed by Stryker's SOMA database, which includes over 37,000 3D bone models generated from CT scans. (Photo: Business Wire)

First European Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

We Are Innovation and Anglo-American University Hosted the Exclusive Premiere of "How Sweden Quit Smoking"

Using the international distress signal “SOS” (which conventionally stands for Save Our Souls) and imagery depicting a skull with crossbones which represents a deadly road hazard ahead, this global advocacy initiative urgently underscores the critically flawed state of the World Health Organization's (WHO) Pandemic Agreement as negotiations near conclusion at the end of May. (Graphic: Business Wire)

Global SOS: Urgent Call to Revamp Pandemic Negotiations

Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration

Slimming World Kitchen Recipe Box

Slimming World launches innovative new recipe box service – Slimming World Kitchen

BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi®

Manufactured by Kolmar BNH and distributed by Atomy, HemoHIM G, containing Angelica sinensis, Ligusticum chuanxiong, and Paeonia lactiflora, is now available in Taiwan. (Photo: Kolmar BNH)

Kolmar BNH Expands Its Global Market by Launching HemoHIM G in Taiwan

Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress

MEDSIR & Debiopharm Initiate Clinical Collaboration to Explore Potential Synergy of Debio 0123 & Sacituzumab Govitecan in Advanced Breast Cancer

PR Newswire associated0

Kinomica, King's College London and King's College Hospital NHS Foundation Trust to Present Research Abstract at the 2024 ASCO Annual Meeting